Journal of Cardiovascular Electrophysiology · 2021 · 84 citations · 30 references
The DECAAF II trial is the first prospective, randomized, multicenter trial of patients with persistent AF using imaging defined atrial fibrosis as a treatment target. The trial will help define an optimal approach to catheter ablation of persistent AF, further our understanding of influencers of ablation lesion formation, and refine selection criteria for ablation based on atrial myopathy burden.
30
Hugh Calkins, Karl Heinz Kuck, Riccardo Cappato et al. · EP Europace · 2012 · 2.7K citations · Full text
Approaches to Catheter Ablation for Persistent Atrial Fibrillation
Atul Verma, Chenyang Jiang, Timothy R. Betts et al. · New England Journal of Medicine · 2015 · 2.2K citations · Full text